Literature DB >> 8682181

Regeneration of entorhino-dentate projections in organotypic slice cultures: mode of axonal regrowth and effects of growth factors.

P L Woodhams1, D J Atkinson.   

Abstract

Explants of Embryonic Day 18 (E18) rat entorhinal cortex were cocultured with Postnatal Day 6 mouse hippocampal slices to study CNS regeneration in vitro. The present report describes a double-labeling paradigm for quantitative analysis of the type of new growth seen in immature cultures. Entorhinal projection neurons in living static cocultures were retrogradely labeled with DiI or Texas red-dextran at 6 days in vitro and with dextran-FITC at 13 days. An intervening lesion to the entorhinodentate pathway was made at 8 days by replacing the hippocampal slices with fresh ones. About one-third of the new efferent entorhinal projections labeled with the second tracer could be characterized as true regeneration of axons from previously projecting entorhinal neurons by virtue of their being double labeled. The remaining two-thirds comprised new, late-arriving axons from previously nonprojecting cells. Earlier studies have shown that rat entorhinal axons will reinnervate hippocampal slices only if the lesions are made before 2-3 weeks in culture, equivalent to a postnatal age of 11-18 days. In a second series of experiments we tested whether treatment with trophic factors could overcome this age-related failure of regeneration characteristic of mature preparations. E18 explants were lesioned after 4 weeks in vitro and grown for a further 2 weeks in medium supplemented with either Schwann cell conditioned medium or acidic fibroblast growth factor plus heparin. A significant increase in outgrowth was seen in both cases, although the effects of each factor were not additive when they were applied in combination. These results show that our model of CNS lesions in vitro can be used to assess the effectiveness of growth factors in ameliorating the decline in regenerative ability with increasing developmental age.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8682181     DOI: 10.1006/exnr.1996.0116

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

1.  Regenerating cortical connections in a dish: the entorhino-hippocampal organotypic slice co-culture as tool for pharmacological screening of molecules promoting axon regeneration.

Authors:  José Antonio del Río; Eduardo Soriano
Journal:  Nat Protoc       Date:  2010-01-21       Impact factor: 13.491

2.  The analysis of neurovascular remodeling in entorhino-hippocampal organotypic slice cultures.

Authors:  Sophorn Chip; Xinzhou Zhu; Josef P Kapfhammer
Journal:  J Vis Exp       Date:  2014-10-23       Impact factor: 1.355

3.  The promises and challenges of human brain organoids as models of neuropsychiatric disease.

Authors:  Giorgia Quadrato; Juliana Brown; Paola Arlotta
Journal:  Nat Med       Date:  2016-10-26       Impact factor: 53.440

4.  MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4.

Authors:  James T Walsh; Sven Hendrix; Francesco Boato; Igor Smirnov; Jingjing Zheng; John R Lukens; Sachin Gadani; Daniel Hechler; Greta Gölz; Karen Rosenberger; Thomas Kammertöns; Johannes Vogt; Christina Vogelaar; Volker Siffrin; Ali Radjavi; Anthony Fernandez-Castaneda; Alban Gaultier; Ralf Gold; Thirumala-Devi Kanneganti; Robert Nitsch; Frauke Zipp; Jonathan Kipnis
Journal:  J Clin Invest       Date:  2015-01-20       Impact factor: 14.808

5.  Brain slices as models for neurodegenerative disease and screening platforms to identify novel therapeutics.

Authors:  Seongeun Cho; Andrew Wood; Mark R Bowlby
Journal:  Curr Neuropharmacol       Date:  2007-03       Impact factor: 7.363

6.  Optimized heterologous transfection of viable adult organotypic brain slices using an enhanced gene gun.

Authors:  Jason Arsenault; John A O'Brien
Journal:  BMC Res Notes       Date:  2013-12-19

Review 7.  Organotypic brain slice cultures: A review.

Authors:  C Humpel
Journal:  Neuroscience       Date:  2015-08-05       Impact factor: 3.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.